Jasper Therapeutics Completes Kira Acquisition and Raises $132M
REDWOOD CITY, Calif., Aug. 14, 2026 asper Therapeutics, Inc. reported continued progress in its immune-mediated disease portfolio following the...
M&A
Advertisement
Teledyne to Acquire Varex Imaging in $1.1 Billion Deal Today
Thousand Oaks, California & Salt Lake City, Utah, August, 10, 2026 Teledyne Technologies Incorporated and Varex Imaging Corporation have...
Grifols Completes SPARTA Phase 3 Trial of Prolastin-C
Bridgewater, N.J., August 10, 2026 Grifols announced the completion of patient follow-up in SPARTA, its Phase 3 outcomes study...
Amneal Completes Kashiv BioSciences Acquisition to Expand Biosimilars
Bridgewater, N.J., August 10, 2026 Amneal Pharmaceuticals, Inc. has completed its acquisition of Kashiv BioSciences, LLC, creating a scaled,...
Ceribell Secures CMS NTAP for Delirium Monitor System
SUNNYVALE, Calif., Aug. 3, 2026 Ceribell, Inc. has secured a significant reimbursement milestone after the U.S. Centers for Medicare...
Advertisements
Supernus Pharmaceuticals and Indivior to Merge in $2.2 Billion CNS Biopharma Deal
ROCKVILLE, Md. & RICHMOND, Va., Aug. 3, 2026 Supernus Pharmaceuticals and Indivior Pharmaceuticals announced they have entered into a...
IMPACT Therapeutics Licenses Senaparib to Pharmanovia
SHANGHAI, July 31, 2026 IMPACT Therapeutics announced an exclusive licensing agreement with Pharmanovia, granting the global specialty pharmaceutical company...
argenx SE Expands Immunology Pipeline with Forte Biosciences Deal
Amsterdam, the Netherlands and Dallas, Texas – July 27, 2026 argenx has entered into a definitive agreement to acquire...
AdaptHealth Signs Definitive Sale Agreement with Cardinal Health
Conshohocken, Pennsylvania, USA | July 20, 2026 AdaptHealth Corp. has entered into a definitive agreement to sell its Diabetes...
Samsung Biologics to Acquire PolyPeptide for CHF 1.46B
INCHEON, South Korea, July 20, 2026 Samsung Biologics has announced a landmark all-cash public tender offer to acquire 100%...
Advertisement
